Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-24 @ 3:54 PM
NCT ID: NCT03703492
Eligibility Criteria: Inclusion Criteria: * Diagnosis of biopsy-proven DCIS without invasion or microinvasion measuring at least 1.0 cm in diameter by any imaging modality * Undergoing diagnostic breast MRI ordered by the referring clinician for staging and extent of disease Exclusion Criteria: * Inability or unwillingness to provide informed consent to the study * Surgery, radiation, neoadjuvant chemo/endocrine therapy for the current malignancy prior to study enrollment * Participants currently taking or have taken an ER-blocking medication (e.g. tamoxifen, raloxifene) within 6 weeks prior to study enrollment * Pregnant or lactating women * Participant with intolerance or contraindications for MRI or gadolinium-based contrast agents * Participant girth exceeds the bore of the MRI/PET scanner * Participants with a history of allergic reaction attributable to compounds of similar chemical or biologic composition to 18F-FES * Participants in liver failure as judged by the patient's physician, due to the hepatobiliary clearance of 18F-FES * Participants requiring intravenous (IV) conscious sedation for imaging are not eligible; participants requiring mild, oral anxiolytics for the clinical MRI will be allowed to participate as long as the following criteria are met: * The participant has their own prescription for the medication * The informed consent process is conducted prior to the self-administration of this medication * They come to the research visit with a driver or an alternative plan for transportation (e.g. Uber, taxi, etc.)
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Study: NCT03703492
Study Brief:
Protocol Section: NCT03703492